These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 37254663)

  • 1. Organ-on-chip systems as a model for nanomedicine.
    Stavrou M; Phung N; Grimm J; Andreou C
    Nanoscale; 2023 Jun; 15(23):9927-9940. PubMed ID: 37254663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ-on-a-Chip: A Preclinical Microfluidic Platform for the Progress of Nanomedicine.
    Rodrigues RO; Sousa PC; Gaspar J; Bañobre-López M; Lima R; Minas G
    Small; 2020 Dec; 16(51):e2003517. PubMed ID: 33236819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microfluidic Devices: A Tool for Nanoparticle Synthesis and Performance Evaluation.
    Gimondi S; Ferreira H; Reis RL; Neves NM
    ACS Nano; 2023 Aug; 17(15):14205-14228. PubMed ID: 37498731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational Nanomedicines Across Human Reproductive Organs Modeling on Microfluidic Chips: State-of-the-Art and Future Prospects.
    Sood A; Kumar A; Gupta VK; Kim CM; Han SS
    ACS Biomater Sci Eng; 2023 Jan; 9(1):62-84. PubMed ID: 36541361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-on-a-chip platforms for assessing nanoparticle-based cancer therapy.
    Wang Y; Cuzzucoli F; Escobar A; Lu S; Liang L; Wang S
    Nanotechnology; 2018 Aug; 29(33):332001. PubMed ID: 29794338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microfluidics for nanomedicines manufacturing: An affordable and low-cost 3D printing approach.
    Tiboni M; Tiboni M; Pierro A; Del Papa M; Sparaventi S; Cespi M; Casettari L
    Int J Pharm; 2021 Apr; 599():120464. PubMed ID: 33713759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidic and lab-on-a-chip preparation routes for organic nanoparticles and vesicular systems for nanomedicine applications.
    Capretto L; Carugo D; Mazzitelli S; Nastruzzi C; Zhang X
    Adv Drug Deliv Rev; 2013 Nov; 65(11-12):1496-532. PubMed ID: 23933616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles.
    Ozcelikkale A; Moon HR; Linnes M; Han B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28198106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidic formulation of nanoparticles for biomedical applications.
    Shepherd SJ; Issadore D; Mitchell MJ
    Biomaterials; 2021 Jul; 274():120826. PubMed ID: 33965797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the Human Body on Microfluidic Chips.
    Jalili-Firoozinezhad S; Miranda CC; Cabral JMS
    Trends Biotechnol; 2021 Aug; 39(8):838-852. PubMed ID: 33581889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From organ-on-chip to body-on-chip: The next generation of microfluidics platforms for in vitro drug efficacy and toxicity testing.
    Lacombe J; Soldevila M; Zenhausern F
    Prog Mol Biol Transl Sci; 2022; 187(1):41-91. PubMed ID: 35094781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine.
    Carvalho MR; Barata D; Teixeira LM; Giselbrecht S; Reis RL; Oliveira JM; Truckenmüller R; Habibovic P
    Sci Adv; 2019 May; 5(5):eaaw1317. PubMed ID: 31131324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seeking the right context for evaluating nanomedicine: from tissue models in petri dishes to microfluidic organs-on-a-chip.
    Zhang YS; Khademhosseini A
    Nanomedicine (Lond); 2015; 10(5):685-8. PubMed ID: 25816872
    [No Abstract]   [Full Text] [Related]  

  • 14. Cultivating human tissues and organs over lab-on-a-chip models: Recent progress and applications.
    Bhagat S; Singh S
    Prog Mol Biol Transl Sci; 2022; 187(1):205-240. PubMed ID: 35094775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microfluidic-Based Platform for the Evaluation of Nanomaterial-Mediated Drug Delivery: From High-Throughput Screening to Dynamic Monitoring.
    Yang Y; Liu S; Geng J
    Curr Pharm Des; 2019; 25(27):2953-2968. PubMed ID: 31362686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical design parameters to develop biomimetic organ-on-a-chip models for the evaluation of the safety and efficacy of nanoparticles.
    Abdelkarim M; Perez-Davalos L; Abdelkader Y; Abostait A; Labouta HI
    Expert Opin Drug Deliv; 2023 Jan; 20(1):13-30. PubMed ID: 36440475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system.
    Tian C; Zheng S; Liu X; Kamei KI
    J Nanobiotechnology; 2022 Jul; 20(1):338. PubMed ID: 35858898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microfluidics for studying metastatic patterns of lung cancer.
    Ruzycka M; Cimpan MR; Rios-Mondragon I; Grudzinski IP
    J Nanobiotechnology; 2019 May; 17(1):71. PubMed ID: 31133019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current developments and applications of microfluidic technology toward clinical translation of nanomedicines.
    Liu D; Zhang H; Fontana F; Hirvonen JT; Santos HA
    Adv Drug Deliv Rev; 2018 Mar; 128():54-83. PubMed ID: 28801093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ-on-Chips for Studying Tissue Barriers: Standard Techniques and a Novel Method for Including Porous Membranes Within Microfluidic Devices.
    Ballerini M; Jouybar M; Mainardi A; Rasponi M; Ugolini GS
    Methods Mol Biol; 2022; 2373():21-38. PubMed ID: 34520004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.